Abstract-The aim of this work was to assess lesion detectability and quantification in whole body oncological 18 F-FDG studies performed by a state-of-the-art integrated Positron Emission Tomograph/computed tomography (PET/CT) system. Lesion detectability and quantification were assessed by a Monte Carlo (MC) simulation approach as a function of different physical factors (e.g., attenuation and scatter), image counting statistics, lesion size and position, lesion-to-background radioactivity concentration ratio (L/B), and reconstruction algorithms. The results of this work brought to a number of conclusions.
• The MC code PET-electron gamma shower (EGS) was accurate in simulating the physical response of the considered PET/CT scanner ( 90%). 
I. INTRODUCTION
T HE diagnostic applications of positron emission tomography (PET) with F-Fluorodeoxyglucose ( F-FDG) in oncology is of growing interest, allowing the detection of neoplastic lesions as foci of increased glucose metabolism (e.g., [1] - [4] ). The recent advent of integrated PET/CT systems makes a more accurate lesion assessment possible. This is based on the simultaneous analysis of fused functional PET and anatomical CT images, CT providing the anatomical size, shape, localization and characterization of the metabolic lesions detected in the PET study (e.g., [5] - [7] ).
However, in PET, lesion detectability is affected by the physical effects associated with PET response (e.g., statistical noise, spatial resolution, scatter and attenuation), with data processing methods (e.g., reconstruction method, correction algorithms), and with factors associated with the clinical conditions of oncological patients (e.g., nonhomogeneity in pathological tissues such as cirrhotic liver and lungs with atelectasis; physiological tracer uptake as occurs in the bladder and kidneys; pathological uptake as occurs in neoplastic lesions and in organs involved in the pathology) (e.g., [8] - [13] . For example, poor PET spatial resolution (4-5 mm) can result in apparent radioactive contamination between the lesion and the surrounding tissues (Partial Volume Effect, PVE) (e.g., [14] , [15] ). For lesions with a size comparable or inferior to 3-4 times the scanner spatial resolution, these effects can severely affect the estimation of radioactivity concentration. As a consequence, degradation in the lesion-to-background contrast can prevent an accurate identification of hyper-metabolic areas and their accurate characterization in terms of size and position, and of metabolic activity as an index of tumour invasiveness [16] - [18] .
A priori knowledge of the limits in PET lesion detectability is crucial to correctly interpret the PET study and make an accurate diagnosis. Also, an accurate quantification of the lesion uptake is necessary to define the invasiveness of the tumour, and correction for PVE is desirable.
In this work, the limits in lesion detectability and quantification accuracy for a state-of-the-art integrated PET/CT system were assessed by Monte Carlo (MC) simulations of realistic anthropomorphic phantoms and patient-derived phantoms, representative of oncological PET F-FDG studies. An investigation was made into the dependence of lesion detectability and lesion quantification on lesion size and system spatial resolution, lesion-to background radioactivity concentration ratio (L/B), counting statistics, attenuation and scatter noise, radiation attenuation and scatter correction, data processing, reconstruction algorithms and nonhomogeneity of background tissues.
II. MATERIALS AND METHODS

A. MC Simulation Model
Monte Carlo simulations of the integrated PET/CT system HD Reveal (CPS Laboratories), Knoxville, TN, [19] were performed. The MC code PET-EGS [20] , [21] , dedicated to the simulation of realistic 3-D PET clinical studies, was used for this purpose. Input to the code were: a) the physical and geometrical characteristics of the PET scanner; b) the radioactivity and attenuation distribution of analytical phantoms or voxelized (image-derived) phantoms. The 3-D re-binned (Fourier) sinograms of true and scattered coincidence events were created from the simulated output list-mode data. Random coincidences were estimated analytically by singles rates, according to [21] , [22] . Total coincidences were obtained by adding sinograms of true, scattered and random coincidences. The physical parameters [23] . Several phantoms were used for validation purposes. Linear sources ( cm, mm) in air at 0, 10, 20 cm and in water at 0, 4, 8 cm (for each position: 20 and 40 M counts measured, 2 and 4 M events simulated in air and water, respectively) were used for the estimation of spatial resolution and scatter fraction. A uniform cylinder ( cm, cm), with a radioactivity concentration of 0.1 Ci/cc (150 M counts measured, 50 M events simulated) was used for the estimation of the detection sensitivity.
B. MC Simulation of PET/CT Oncological Studies
Oncological F-FDG PET studies were simulated by the MC code PET-EGS. For this purpose, voxelized phantoms were created, to which were added artificial lesions of different size (down to the size of system spatial resolution) and different L/B ratios (comparable to those found in clinical situations). Several studies were simulated.
• Zubal phantom study. A digital anthropomorphic phantom was derived from the Zubal phantom [24] . Consideration was given to 70 slices, taken from neck to pelvis. A segmented radioactivity map was created according to [25] . Both activity and attenuation maps were reduced to 128 128 70 (4 4 10 mm voxel size). Six hot lesions of different size ( and mm) and one cold lesion ( cm) were added artificially to the CT/PET images in the abdominal region, as shown in Fig. 1 , top, left. Hounsfield units (HU) were set to zero inside the lesions. L/B ratio were 2, 3, 4 and 5. The background surrounding the lesions was homogeneous. The digital phantom was input to PET-EGS for simulations at different counting statistics and accounting or not for the effect of attenuation (low statistics: 15 M events without simulating attenuation; high statistics: 45 M events without simulating attenuation and 300 M events simulating attenuation).
• Patient-derived phantom studies. A digital realistic phantom was derived from a whole-body tumor staging PET F-FDG study, performed in 2-D mode; the 2-D acquisition modality guaranteed a quantitatively accurate radioactivity distribution and volume representation. Consideration was given to 105 slices taken from neck to pelvis. Both PET emission (scatter and attenuation corrected) and CT attenuation (segmented into soft tissue, lungs and bone) maps were reduced to 128 128 105 (4 4 4.25 mm voxel size); the bed was deleted; 15 hot lesions of different size ( mm) were artificially added to the PET/CT image volume in the abdominal region ( in the lesions). Due to liver cirrhosis, the lesion background was not homogeneous (average activity variation in the liver %, in terms of ). Independent simulations for three different L/B ratios were performed (representative images in Fig. 2 for ). The derived digital phantoms were input to PET-EGS for simulations at different counting statistics and accounting or not for the effect of attenuation (low statistics: 125 M events without simulating attenuation; high statistics: 375 M events without simulating attenuation and 580 M events simulating attenuation). For both simulated Zubal and patient-derived phantom studies the data were generated according to different processing methods (a-p), as summarized in Table I dence events [21] , FBP filter-back-projection reconstruction (Gaussian filter of 6 6 6 mm ), OSEM Order Subset Expectation Minimization iterative reconstruction [27] , (Gaussian filter with a kernel of 4 4 2 mm , 36 sub-sets, filtering every 6 sub-sets). Reconstruction parameters were chosen as optimal with respect to lesion detectability [28] . Method p corresponds to the condition of a real PET F-FDG whole body clinical study.
C. Data Analysis
A total of 56 reconstructed image sets for the Zubal and the patient-derived phantoms, obtained by the fourteen different processing methods (a-p), were analyzed by six human observers (two medical doctors, two graduate students, and two medical physicists, with expertise in PET/CT oncological imaging), who were asked to identify lesions in images by visual inspection, as is done in clinical practice (blind with respect to the image processing method, number of lesions, lesion position, size, and L/B). The analysis was performed on individual image sets, presented in a random order. Full concordance in lesion detection among the six observers was assumed to correspond to a condition of certainty in lesion detection. When a lesion was identified by all observers, aquantitative analysis was performed by calculating recovery coefficients (RC), as (1) where estimated L/B was the lesion-to-background ratio estimated on the lesion volume in the MC simulated emission images, and L/B was the known lesion-to-background ratio in image input to simulations.
III. RESULTS
A. MC Simulation Model
Table II allows the comparison of the simulated and measured physical parameters for the PET/CT HD Reveal scanner.
The accuracy of simulations was %. Table III shows the global results of the qualitative analysis (visual inspection) of simulated images (methods a-p) for the Zubal phantom study. Table IV shows global results of the qualitative analysis (simulated images, methods a-p) for the patientderived phantom studies.
B. MC Simulations of PET/CT Oncological Studies
In Tables III and IV, " yes" means that all the observers detected the lesion (full concordance); "no" that at least one observer did not detect the lesion.
Tables III and IV allow several general considerations to be made.
• Comparing methods a and b shows that image counting statistics play a relevant role in small lesion detectability. • Comparing methods c, d, e, f, g, h (scatter affected images) with methods i, l, m, n, o, p (scatter corrected images) shows that scatter correction improves lesion detectability in most cases.
• Comparing methods c, d (attenuation affected images)
with e, f (attenuation corrected images) shows that, despite attenuation being an important effect for both the phantom studies, attenuation correction does not improve lesion detectability for the Zubal phantom, while in the case of the patient-derived phantom it does. • Comparing methods m, n (randoms affected images) with o, p (randoms corrected images) shows that randoms correction does not improve lesion detectability (random coincidences were % of the total coincidences in these studies).
• Comparing methods c, e, g, i, m, o (FBP) with methods d, f, h, l, n, p (OSEM) in Table IV shows that OSEM reconstruction improves lesion detectability in oncological whole-body studies (as scatter, randoms, and attenuation as well as correction for all these is standard clinical practice).
• The 2 cm cold lesion was detected by all the observers in all cases. • No lesion was identified by any of the observers at .
• In method p, reproducing the clinical conditions, limits in lesion detectability were derived (underlined "yes" in Tables III and IV) for the following studies: a) Zubal phantom study: at for lesion diameter of 8 mm and at for lesion diameter of 5 mm; b) patient-derived phantom studies: at for lesion diameter of 12 mm and at for lesion diameter of 8 mm. With respect to clinical situations (all noise components simulated) it is interesting to note the improvement in lesion detectability when all noise corrections are applied (method p). Method b is better than p but it does not represent a realistic case (no noise components simulated).
In general, better results were found for the Zubal phantom study that presented uniform background organs (liver and lungs) with respect to the patient-derived phantom studies presenting nonuniform cirrhotic liver.
Figs. 1 and 2 show representative images obtained from the MC simulation of the Zubal phantom study and the patient-derived phantom study for , respectively. Due to space limitations, only images obtained by selected processing methods are shown.
In the case of the Zubal phantom in Fig. 1 , the radioactivity image input to the MC code (top, left) and MC simulated PET images obtained by processing methods a, b, c, g, i, l, m, o, p are shown. Lesion size and L/B ratio (2, 3, 4, 5) are indicated in red on the MC input image. On the MC simulated images, the processing method (see Table I ) is shown at the bottom of each processed image. Lesions identified with full concordance among observers are marked with continuous circles, lesions identified without concordance are marked with dash circles. This lesion analysis allowed lesion detectability limits to be determined.
In the case of the patient-derived phantom study in Fig. 2 , a sequence of six images presenting multiple lesions, used as the input radioactivity map to the MC code (row 1), and the corresponding MC simulated PET images obtained by processing methods a, b, d, h, l, i, n, p (rows 2-9 ) are shown.
A qualitative analysis of Figs. 1 and 2 supports the results of Tables III and IV and their interpretation. In fact, the effects of the high counting statistics and of applying scatter correction to improve lesion detectability can be observed. Note that in both Figs. 1 and 2 the arrows indicate lesions whose detection was possible only in high statistics images and following scatter correction. The lack of attenuation correction and the use of a FBP reconstruction algorithm make image interpretation difficult. The former results in severe underestimation of the radioactivity concentration, particularly in deeper body structures, and the latter in a high noise level. Fig. 2 also shows the effect of data re-binning on increasing the apparent axial size of a lesion. For example, the artifactual lesion indicated by the arrow in the central slice of rows 2 and 3 (not present in the original MC input image) is a re-binning effect of the lesion present in an adjacent slice. Such an increasing effect of axial size was found to be up to 2-fold for lesions at the edge of the transaxial field of view. However, it should be noted that in the image reading diagnostic procedure one of the criteria adopted by nuclear medicine physicians to decide the presence of a lesion is its appearance in more than one slice. From this point of view, re-binning did not penalize lesion detectability, having instead an enhancement effect on lesion detection.
A visual assessment of lesion detection in terms of lesion size and L/B ratio can be seen in Fig. 3 for the case of the patient-derived phantom studies. The radioactivity images input to the MC code (row 1) and the corresponding MC simulated PET images obtained by processing method p (clinical method) for (row 2) and (row 3) are shown. The effect of the higher L/B ratio in improving lesion detectability can be observed for the two 8 mm lesions, indicated by arrows (row 3), which were identified concordantly only for (see Table IV ). Furthermore, one lesion of 12 mm (indicated by the arrow in row 1) was never detected by any observer at any L/B ratio (Fig. 2) . This was possibly a degradation effect in spatial resolution at the edge of the scanner field of view, suggesting that lesion position is important to lesion detectability. and the patient-derived phantom (O), are plotted against lesion diameter, normalized to the system spatial resolution (to account for resolution degradation with respect to lesion position in the scanner field of view). Similar RC values were obtained for all L/B ratios. As expected, a severe underestimation of radioactivity concentration occurs in lesions of size 1-4 times the system spatial resolution. As for the qualitative analysis, the Zubal phantom has better RC's values than the patient-derived phantom, confirming the importance to simulate clinical conditions for an accurate quantification.
IV. DISCUSSION AND CONCLUSION
This work started from the need to investigate physical factors affecting lesion detectability in PET whole body studies in oncology, and to consequently optimize PET clinical protocols.
This work had two main characteristics. The first characteristic is represented by the independent control of the different effects affecting lesion detectability and quantification accuracy in PET/CT. This was guaranteed by the use of MC simulation with respect to using an experimental approach. The advantages of a MC method are: a) the full discrimination of signal and noise components (e. g. scatter and random from true coincidence events) and b) the possibility to vary one parameter at a time (see Table I , methods a-p). The second characteristic was the assessment of lesion detectability and quantification accuracy in very realistic conditions. This was guaranteed by MC simulations of "oncological" anthropomorphic digitized phantoms (Zubal and patient-derived phantoms) with counting statistics comparable to that in clinical images (equivalent to approximately 2 minute/bed clinical scans with an injected dose of 10 mCi of F-FDG). The advantages of MC simulation with respect to experimental phantoms are: a) the flexibility to simulate a variety of situations (e.g., small spherical and nonspherical lesions in anthropomorphic phantoms, presenting pathological, and physiological tracer uptake) and b) overcoming difficulties found in experimental studies, such as the accurate knowledge of size, shape, and activity concentration in small lesions. Within this context, we moved one step closer to realistic data by using patient derived data with real cirrhotic liver as the background organ. In fact, the importance of using such realistic data was proved in this work by the different results found for the Zubal phantom with respect to the patient-derived phantom (e.g., in terms of the effects of attenuation correction, iterative reconstruction, and limits in lesion detectability).
This work had three main achievements. A first achievement was the definition of physical criteria to address patients to a PET/CT study and to interpret negative PET findings. The results of this work in terms of limits in lesion detectability indicate that, for the considered PET/CT scanner, PET lesions can be detected if their size is greater than approximately 1 cm and the lesion tracer uptake is at least four times the uptake in the surrounding background. A second achievement was the investigation of the role of different factors affecting lesion detectability and quantification accuracy, including physical effects in the PET acquisition process, effects associated with data processing and corrections, nuisance effects due, for example, to nonhomogeneity in organs surrounding lesions, as occurs for textured or "lumpy" organs (e.g., cirrhotic liver). Based on the results of this study PET acquisition and processing protocols were optimized in our PET center, in order to improve lesion detectability. For example, the study confirms the importance of high counting statistics in detecting a lesion. If a PET study yields images of poor quality, not allowing certainty in lesion detection, then, without moving the patient, a further PET scan is performed and added to the first study to improve the signal-to-noise ratio and thus lesion detection. Attenuation, scatter and random correction, as well as re-binning and iterative algorithms, are also part of the clinical protocol implemented in oncological PET studies. A third achievement was the assessment of the feasibility of a MC-based PVE correction method. In fact, quantitative or semi-quantitative (e.g., SUV) measurement of the tracer uptake in a tumor allows tumor malignancy to be assessed, also during follow up. From this work, a method can be developed to correct for PVE: as lesion size can be known (e.g., from CT images) and lesion PVE-affected uptake can be measured from PET images, use can be made of a look-up table of recovery coefficients, estimated by the MC method for different lesion sizes and L/B ratios.
Further investigations on lesion classification by human observer analysis (e.g., in terms of true/false positives and negatives) could be performed by taking advantage of the adopted MC approach that provides a priori knowledge of lesion characteristics. These investigations are required in order to assess the issue of sensitivity and specificity. They could have a significant bearing on the clinical utility of their results.
Aim of this work was the investigation of lesion detectability and quantification accuracy in PET F-FDG whole-body studies in oncology. Although obtained for a selected anatomical region (abdomen) and for a limited number of conditions of interest, the results of this work are representative of the potentials of the approach adopted (use of MC simulations of very realistic patient-derived phantoms) and of the clinical value of the information which can be achieved (limits in lesion detectability, recovery coefficients for PVE correction).
